Monthly reportEDA
Egyptian Drug Authority — August 2022
What this register recorded from EDA in August 2022, what other African authorities published in the same month that bears on it, and what we could not read in EDA’s own notices. Every figure here is a count of published regulatory actions. None of it is a finding about Egyptian Drug Authority.
What EDA published
| Reference | Date | Country | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-EG-2022-0021 | 17 Aug 2022 | EG | Xolamol sterile ophthalmic solution | YG0158 | Seizure & destruction | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2022-0022 | 23 Aug 2022 | EG | Ivermectin 2% lotion 60 ml | 2022/6241 | Seizure & destruction | Unclassified | Tier 1 · Regulator-published |
| DEA-EG-2022-0023 | 24 Aug 2022 | EG | Ivy Cough syrup كرمان للصناعات الدوائية والكيماويات | none published | Seizure & destruction | Unclassified | Tier 1 · Regulator-published |
What other authorities published
What we could not read in EDA’s notices
- 336 record(s) held from EDA in total
- 5 carry no publication date we could read
- 43 name neither a batch nor a stated reason
- 247 name no manufacturer
- 5 are searchable and API-available but carry noindex, because they are too incomplete for a public URL
- 0 have no archived copy of the original notice
Correcting this
Anything on this page that is wrong about Egyptian Drug Authority can be corrected by Egyptian Drug Authority, and a record published by one of its officers carries verification tier 0 — the rank only the issuing regulator can create. Nothing else on this register does.